:: Popular Co. Ltd. :: Our statistical analysis :: Treatment the most advanced stages of cancer using neogalenic phytomedications such as flaraxin. New phytotherapeutic schemes of cure in oncology. Research of antitumor preparations from herbs.

COMPARATIVE CHARACTERISTICS OF THE NEOHALENIC MEDICATIONS
(by main and side effects)

MEDICATION (trade mark)	PHARMACEUTICAL FORM	DOSAGE (dayly dose)	EFFECT				TOXYCITY (international 5 gr. scale)	ACCESSIBILITY
MEDICATION (trade mark)	PHARMACEUTICAL FORM	DOSAGE (dayly dose)	1	2	3	4	TOXYCITY (international 5 gr. scale)	ACCESSIBILITY
Tropofin	amp.	every 6 hours	4	4	1	5	2	3
Metacistin	amp.	every 12 hours	3	4	5	2	3	2
Fitomaks	tab., supp.	individual scheme	1	1	4	4	1	1
Fitor	tab., supp.	individual scheme	1	1	3	4	1	1
Flaraxin	sm. bottle	once a day	4	3	5	5	0-1	3
Fitotrol	sm. bottles, supp.	once a day	5	3	2	3	0-1	5
Salbifit	caps., supp.	individual scheme	2	4	5	3	3	1
Alometastat	amp.	once a day	4	5	2	2	4	1
Giniprofit	supp., dragee	individual scheme	2	3	4	5	0-1	1
Theomitosit	amp.	once per 3 days	5	4	1	3	1-2	4
Multiimmun	sm. bottles., supp.	once a day	2	3	5	5	0	4
Taylecitin	sm. bottles, tab.	twice a day	4	5	1	4	2	5
Lisophitostat	amp., supp.	once a day	3	5	5	3	1-2	1
Flegaxin	sm. bottles, amp.	once per 5 days	3	3	5	5	0-1	5

Comments: Effect:	*1st column -*	antimitotic
	*2nd column -*	antimetastatic
	*3rd column -*	immunomodulation
	*4th column -*	metabolic

I. Pharmacological activity and clinical effects:
1 - low, 2 - below average, 3 - average, 4 - above average, 5 - high
II. Accessibility of the medications on the international market (by price):
1 - significantly below average, 2 - below average, 3 - average price in group, 4 - above average, 5 - significantly above average.

Analysis of the results of oncologic diseased people treatment and the effectiveness and toxicity of the preparations

Type of tumor by morphological characteristics:
Stomach, breast (mammary gland), lungs, intestines.

Pharmacological characteristics of used phytomedications.

Results of treatment neoplasms of different locations
(only IV stage)

Disease	Results of treatment
	After 1st course					After 2nd course					After 3 and more courses
	Total	improvement		without changes		Total	improvement		without changes		Total	improvement		without changes
Units		abs.	%	abs.	%		abs.	%	abs.	%		abs.	%	abs.	%
Stomach cancer	28	11	39.2	17	60.7	9	7	77	2	23	5	3	60	2	40
Pancreas cancer	11	4	36	7	64	8	5	63	3	37	7	7	100	-	-
Breast cancer	97	57	58.1	41	41.8	69	40	57.9	29	42	29	16	55.1	13	44.8
Larynx cancer	10	6	60	4	40	2	2	100	-	-	6	4	66	2	33
Bronchi cancer	14	8	57	6	43	8	4	50	4	50	9	8	88	1	22
Lungs cancer	27	12	44.4	15	55.5	23	11	47.8	12	52.1	12	9	75	3	25
Colon cancer	14	4	28.5	10	71.4	6	2	33.3	4	66.6	5	1	20	4	80
Prostate cancer	7	3	43	4	57	-	-	-	-	-	1	1	100	-
Bladder cancer	3	2	67	1	33	1	1	100	-	-	3	2	67	1	33
Kidneys cancer	2	1	50	1	50	2	2	100	-	-	2	1	50	1	50
Lymphatic system cancer	5	3	60	2	40	5	2	40	3	60	5	4	80	1	20
Thyroid gland cancer	2	1	100	1	100	-	-	-	-	-	1	1	100	-	-
Brain cancer	5	3	60	2	40	1	1	100	-	-	5	4	80	1	20
Melanoma	4	3	75	1	25	1	1	100	-	-	6	5	83	1	17

Stomach

Stage of the cancer	Results of treatment
	After 1st course				After 2nd course					After 3 and more courses
	improvement		without changes		Total	improvement		without changes		Total	improvement		without changes
Number	abs.	%	abs.	%		abs.	%	abs.	%		abs.	%	abs.	%
Incl. Total 24	18	75	6	25	14	10	71	4	29	14	12	86	2	14
III st. 1	1	100	-	-	1	1	100	-	-	-	-	-	-	-
IV st. 23	17	74	6	26	13	9	69.2	4	30.8	14	12	85.7	2	14.3

Top of page

Breast

Stage of the cancer	Results of treatment
	After 1st course				After 2nd course					After 3 and more courses
	improvement		without changes		Total	improvement		without changes		Total	improvement		without changes
Number	abs.	%	abs.	%		abs.	%	abs.	%		abs.	%	abs.	%
Incl. Total 53	36	68	17	32	44	33	75	11	25	34	26	76	8	24
III st. 4	4	100	-	-	1	1	100	-	-	-	-	-	-	-
IV st. 49	32	65.3	17	34.7	43	32	74.4	11	25.6	33	25	75.8	8	24.2

Top of page

Lungs

Stage of the cancer	Results of treatment
	After 1st course				After 2nd course					After 3 and more courses
	improvement		without changes		Total	improvement		without changes		Total	improvement		without changes
Number	abs.	%	abs.	%		abs.	%	abs.	%		abs.	%	abs.	%
Incl. Total 48	31	65	17	35	39	30	77	9	23	19	15	79	4	21
III st. 2	1	50	1	50	1	-	-	1	100	-	-	-	-	-
IV st. 46	30	65.2	16	34.8	38	30	78.9	8	21	19	15	79	4	21

Top of page

Colon

Stage of the cancer	Results of treatment
	After 1st course				After 2nd course					After 3 and more courses
	improvement		without changes		Total	improvement		without changes		Total	improvement		without changes
Number	abs.	%	abs.	%		abs.	%	abs.	%		abs.	%	abs.	%
Incl. Total 39	24	62	15	38	21	17	81	4	19	19	16	84	3	16
III st. 2	2	100	-	-	1	1	100	-	-	-	-	-	-	-
IV st. 37	22	59.5	15	40.5	20	16	80	4	20	19	16	84.2	3	15.8

Top of page

Toxicity and efficiency of used phytomedications in comparison with classical chemotherapeutic medications.

Medication	Effect	Toxicity
Medication	Effect	0	1	2	3	4
Phyto- medications	90 - 100	0 - 1	0 - 1	0 - 1	0 - 1	0 - 1
Nitrozo- methyl urea	15 - 20	2 - 3	2 - 3	2 - 3	2 - 3	2 - 3
Poly- chemo- therapy	20 - 30	2 - 3	2 - 3	2 - 3	3 - 3	3 - 4

Comment: The table is developed accounting the clinical data of effectiveness and toxic rates of methods according to the test table:
N.I.Perevodchikova, Antitumor therapy, M., "Medicina" 1986, p. 36 - 37, 166.

Make conclusions by yourself.

Top of page